View Press Releases
-
X4 Pharmaceuticals Receives Orphan Drug Designation from European Commission for Mavorixafor for Treatment of WHIM Syndrome
CAMBRIDGE, MA, US - Jul 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the European Commission (EC), based on a favorable recommendation from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation (ODD) to mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease caused by genetic mutations in the CXCR4 receptor gene
Jul 30, 2019
-
Trinity Cyber Secures $23 Million in Funding, Led by Intel Capital, to Redefine Cybersecurity by Proactively Disrupting Cyber Attacks
BOWIE, MD - Jul 30, 2019 - Start-up Trinity Cyber achieved a major milestone with its closure today on $23 million in funding from top institutional investors led by Intel Capital
Jul 30, 2019
-
Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform
PRINCETON, NJ - Jul 30, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19
Jul 30, 2019
-
BOC Sciences Offers Inhibitor Eribulin for Breast Cancer Research
SHIRLEY, NY, NY, UNITED STATES - Jul 30, 2019 - The world's leading chemical vendor BOC Sciences announces at its headquarter in New York to release a featuring inhibitor chemical – eribulin – for researchers who are involved with breast cancer research in the pharmaceutical industry
Jul 29, 2019
-
Microway Appoints Lorne Wilson as COO
PLYMOUTH, MA - Jul 29, 2019 - Microway Appoints Lorne Wilson as COOExperienced IT executive to lead company operations toward continued growth Microway, a leading provider of fully integrated and validated computational clusters, servers, and workstations for AI and HPC, announces the appointment of Lorne Wilson as Chief Operating Officer
Jul 29, 2019
-
TrialScope Taps Industry Veteran as CTO
BURLINGTON, NJ, UNITED STATES - Jul 29, 2019 - TrialScope, the global leader in clinical trial transparency and compliance solutions, announces the appointment of Ruben Echandy as Chief Technology Officer
Jul 29, 2019
-
Chr. Hansen adopts NiceLabel technology to support mission-critical production
REDONDO BEACH, CA - Jul 25, 2019 - Chr. Hansen develops and produces cultures, enzymes, probiotics and natural colors for the food, confectionary, beverages, dietary supplements and animal feed industries
Jul 25, 2019
-
Creative Biolabs Released Anti-CD20 Immunocytokine for Autoimmune Diseases
SHIRLEY, NY - Jul 23, 2019 - Over the last ten years, Creative Biolabs has made great progress in the field of recombinant antibody discovery and manufacturing, and now has been one of the best leaders and suppliers in antibody production field
Jul 22, 2019
-
Operations commence at Wasdell Group’s EU headquarters
- Jul 19, 2019 - The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical industry, has today announced its new state-of-the-art facility in Dundalk, Ireland has received its Manufacturers / Importation Authorisation licence (MIA) from the Health Products Regulatory Authority (HPRA)
Jul 19, 2019
-
Stimwave Appoints Regina E. Groves and Marc A. Loev, M.D., to Board of Directors and James M. Rallo as Chief Financial Officer
NEW YORK, NY, UNITED STATES - Jul 17, 2019 - Stimwave Technologies, the leading innovator of wireless medical pain relief implant bioelectric technology, has announced the appointments of Regina E
Jul 18, 2019
-
BetterPT Partners with Kno2 to Establish Interoperable Referral Network to Fill the Information Gap in Physical Therapy
NEW YORK, NY, UNITED STATES - Jul 18, 2019 - BetterPT, a healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients and physicians, and Kno2®, the company that provides Interoperability as a Service to everyone in healthcare, today announced plans to launch a fully interoperable referral network that bridges the gap between physician referrers and PTs, enhancing greater patient access to physical therapy
Jul 18, 2019
-
Certara Expands its Drug Evidence & Access Capabilities Through the Addition of Compass Strategic Consulting’s Team
PRINCETON, NJ - Jul 18, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the entire staff from Compass Strategic Consulting (Compass) has joined Certaras Evidence & Access group
Jul 18, 2019
-
CILcare, world-leading R&D company specialized in the field of hearing, celebrates 5 years of success
MONTPELLIER, FRANCE - Jul 18, 2019 - CILcare was created in July 2014 by three managers from Sanofi, Celia Belline, Dr. Marie-Pierre Pasdelou and Dr
Jul 18, 2019
-
The Pistoia Alliance to Develop a Toolkit to Support Implementation of the FAIR Guiding Principles
BOSTON, MA, UNITED STATES - Jul 17, 2019 - The Pistoia Alliance, a global non-profit that works to lower barriers to innovation in life sciences R&D, today announced the launch of its FAIR Implementation project, backed by pharmaceutical companies including Roche, Astra Zeneca, and Bayer
Jul 17, 2019
-
Creative Diagnostics Introduces Innovative Exosome Quantification Immunoassay Kits
SHIRLEY, NY, UNITED STATES - Jul 17, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed and optimized an innovative technology (ExoAssay) that allows specific capture of exosomes from different biological samples, including cell culture supernatants and human biological fluids (plasma, serum, urine, saliva)
Jul 16, 2019
-
BOC Sciences Improves Superparamagnetic Iron Oxide Nano/Micro Particles Preparation for Chemotherapy Research
SHIRLEY, NY, NY, UNITED STATES - Jul 17, 2019 - Having been serving the chemical industry for nearly two decades, BOC Sciences announces to continuously improve its Superparamagnetic Iron Oxide Nano/Micro Particles Preparation service, in order to help researchers engaged with chemotherapy study find a cure for some major diseases that are inflicting the human beings
Jul 16, 2019
-
Creative Peptides Adds an Exclusive Section for Cancer Research
LONG ISLAND CITY, NY, UNITED STATES - Jul 17, 2019 - As one of the global leading peptide suppliers, Creative Peptides announced to add an exclusive section of peptides for researchers who are committed to exploring an effective solution for issues related to cancer research
Jul 16, 2019
-
Rho Announces New Resource for Behavioral and Social Science Researchers to Prepare Research Protocols
DURHAM, NC - Jul 17, 2019 - Rho Announces New Resource for Behavioral and Social ScienceResearchers to Prepare Research ProtocolsCRO facilitated Trans-NIH committee to develop protocol template with NIDCR Research Triangle Park, NC - July 16, 2019 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that Rho's Principal Research Scientist and Program Lead Nancy Yovetich, PhD, and Project Manager Lisa Busko participated in a trans-NIH + extramural committee to develop a standardized protocol template for behavioral and social science researchers
Jul 16, 2019
-
Research: State of Application Security at World's 100 Largest Banks
BIRMINGHAM, GB - Jul 11, 2019 - Industry analysts and security practitioners unanimously concur that application security is a big deal
Jul 11, 2019
-
Atlantic Research Group Selects Greenphire to Improve the Patient Experience for its Rare Disease and Oncology Clinical Trials
KING OF PRUSSIA, PA, UNITED STATES - Jul 9, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that it has been selected by Atlantic Research Group (ARG), a rare and neurodegenerative disease, oncology and immunology-focused contract research organization (CRO) to implement its ClinCard and ConneX solutions to improve the clinical trial experience for sites and patients
Jul 9, 2019